vs
盖茨工业（GTES）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
盖茨工业的季度营收约是Royalty Pharma plc的1.4倍（$856.2M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 6.0%，领先28.4%），Royalty Pharma plc同比增速更快（4.8% vs 3.2%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -0.4%）
盖茨工业总部位于美国科罗拉多州丹佛市，是动力传动带及流体动力产品的专业制造商，产品广泛应用于各类工业和汽车领域。公司员工规模超1.5万人，在美洲、欧洲、亚洲、澳洲及中东均设有销售和生产基地。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
GTES vs RPRX — 直观对比
营收规模更大
GTES
是对方的1.4倍
$622.0M
营收增速更快
RPRX
高出1.5%
3.2%
净利率更高
RPRX
高出28.4%
6.0%
两年增速更快
RPRX
近两年复合增速
-0.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $856.2M | $622.0M |
| 净利润 | $51.3M | $214.2M |
| 毛利率 | 38.0% | — |
| 营业利润率 | 12.8% | 62.4% |
| 净利率 | 6.0% | 34.4% |
| 营收同比 | 3.2% | 4.8% |
| 净利润同比 | 40.2% | 2.9% |
| 每股收益（稀释后） | $0.19 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GTESRPRX
| Q4 25 | $856.2M | $622.0M | ||
| Q3 25 | $855.7M | $609.3M | ||
| Q2 25 | $883.7M | $578.7M | ||
| Q1 25 | $847.6M | $568.2M | ||
| Q4 24 | $829.4M | $593.6M | ||
| Q3 24 | $830.7M | $564.7M | ||
| Q2 24 | $885.5M | $537.3M | ||
| Q1 24 | $862.6M | $568.0M |
净利润GTESRPRX
| Q4 25 | $51.3M | $214.2M | ||
| Q3 25 | $81.6M | $288.2M | ||
| Q2 25 | $56.5M | $30.2M | ||
| Q1 25 | $62.0M | $238.3M | ||
| Q4 24 | $36.6M | $208.2M | ||
| Q3 24 | $47.6M | $544.0M | ||
| Q2 24 | $70.7M | $102.0M | ||
| Q1 24 | $40.0M | $4.8M |
毛利率GTESRPRX
| Q4 25 | 38.0% | — | ||
| Q3 25 | 39.9% | — | ||
| Q2 25 | 40.8% | — | ||
| Q1 25 | 40.7% | — | ||
| Q4 24 | 40.4% | — | ||
| Q3 24 | 40.4% | — | ||
| Q2 24 | 40.4% | — | ||
| Q1 24 | 38.3% | — |
营业利润率GTESRPRX
| Q4 25 | 12.8% | 62.4% | ||
| Q3 25 | 13.5% | 70.1% | ||
| Q2 25 | 13.1% | 36.3% | ||
| Q1 25 | 14.7% | 94.0% | ||
| Q4 24 | 13.6% | 60.9% | ||
| Q3 24 | 13.6% | — | ||
| Q2 24 | 15.4% | 50.2% | ||
| Q1 24 | 13.5% | -13.0% |
净利率GTESRPRX
| Q4 25 | 6.0% | 34.4% | ||
| Q3 25 | 9.5% | 47.3% | ||
| Q2 25 | 6.4% | 5.2% | ||
| Q1 25 | 7.3% | 41.9% | ||
| Q4 24 | 4.4% | 35.1% | ||
| Q3 24 | 5.7% | 96.3% | ||
| Q2 24 | 8.0% | 19.0% | ||
| Q1 24 | 4.6% | 0.8% |
每股收益（稀释后）GTESRPRX
| Q4 25 | $0.19 | $0.49 | ||
| Q3 25 | $0.31 | $0.67 | ||
| Q2 25 | $0.22 | $0.07 | ||
| Q1 25 | $0.24 | $0.55 | ||
| Q4 24 | $0.15 | $0.46 | ||
| Q3 24 | $0.18 | $1.21 | ||
| Q2 24 | $0.26 | $0.23 | ||
| Q1 24 | $0.15 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $812.1M | $618.7M |
| 总债务越低越好 | $2.2B | $9.0B |
| 股东权益账面价值 | $3.3B | $9.7B |
| 总资产 | $7.2B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.67× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资GTESRPRX
| Q4 25 | $812.1M | $618.7M | ||
| Q3 25 | $689.4M | $938.9M | ||
| Q2 25 | $719.7M | $631.9M | ||
| Q1 25 | $640.2M | $1.1B | ||
| Q4 24 | $682.0M | $929.0M | ||
| Q3 24 | $574.4M | $950.1M | ||
| Q2 24 | $579.7M | $1.8B | ||
| Q1 24 | $522.2M | $843.0M |
总债务GTESRPRX
| Q4 25 | $2.2B | $9.0B | ||
| Q3 25 | $2.2B | $8.9B | ||
| Q2 25 | $2.3B | $8.0B | ||
| Q1 25 | $2.3B | $7.6B | ||
| Q4 24 | $2.4B | $7.6B | ||
| Q3 24 | $2.4B | $7.6B | ||
| Q2 24 | $2.3B | $7.6B | ||
| Q1 24 | $2.3B | $6.1B |
股东权益GTESRPRX
| Q4 25 | $3.3B | $9.7B | ||
| Q3 25 | $3.4B | $9.6B | ||
| Q2 25 | $3.3B | $9.5B | ||
| Q1 25 | $3.1B | $9.8B | ||
| Q4 24 | $3.0B | $10.3B | ||
| Q3 24 | $3.1B | $10.3B | ||
| Q2 24 | $3.2B | $9.8B | ||
| Q1 24 | $3.2B | $9.9B |
总资产GTESRPRX
| Q4 25 | $7.2B | $19.6B | ||
| Q3 25 | $7.1B | $19.3B | ||
| Q2 25 | $7.2B | $18.3B | ||
| Q1 25 | $6.9B | $17.6B | ||
| Q4 24 | $6.8B | $18.2B | ||
| Q3 24 | $7.1B | $18.0B | ||
| Q2 24 | $7.0B | $17.7B | ||
| Q1 24 | $7.0B | $16.1B |
负债/权益比GTESRPRX
| Q4 25 | 0.67× | 0.92× | ||
| Q3 25 | 0.66× | 0.93× | ||
| Q2 25 | 0.72× | 0.84× | ||
| Q1 25 | 0.75× | 0.78× | ||
| Q4 24 | 0.78× | 0.74× | ||
| Q3 24 | 0.76× | 0.74× | ||
| Q2 24 | 0.73× | 0.78× | ||
| Q1 24 | 0.74× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $269.8M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $251.0M | — |
| 自由现金流率自由现金流/营收 | 29.3% | — |
| 资本支出强度资本支出/营收 | 2.2% | — |
| 现金转化率经营现金流/净利润 | 5.26× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $404.9M | — |
8季度趋势，按日历期对齐
经营现金流GTESRPRX
| Q4 25 | $269.8M | $827.1M | ||
| Q3 25 | $98.0M | $702.6M | ||
| Q2 25 | $103.0M | $364.0M | ||
| Q1 25 | $7.3M | $596.1M | ||
| Q4 24 | $190.9M | $742.5M | ||
| Q3 24 | $115.9M | $703.6M | ||
| Q2 24 | $93.8M | $658.2M | ||
| Q1 24 | $-21.0M | $664.6M |
自由现金流GTESRPRX
| Q4 25 | $251.0M | — | ||
| Q3 25 | $80.5M | — | ||
| Q2 25 | $83.6M | — | ||
| Q1 25 | $-10.2M | — | ||
| Q4 24 | $167.6M | — | ||
| Q3 24 | $94.0M | — | ||
| Q2 24 | $71.9M | — | ||
| Q1 24 | $-37.0M | — |
自由现金流率GTESRPRX
| Q4 25 | 29.3% | — | ||
| Q3 25 | 9.4% | — | ||
| Q2 25 | 9.5% | — | ||
| Q1 25 | -1.2% | — | ||
| Q4 24 | 20.2% | — | ||
| Q3 24 | 11.3% | — | ||
| Q2 24 | 8.1% | — | ||
| Q1 24 | -4.3% | — |
资本支出强度GTESRPRX
| Q4 25 | 2.2% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 2.2% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 2.8% | — | ||
| Q3 24 | 2.6% | — | ||
| Q2 24 | 2.5% | — | ||
| Q1 24 | 1.9% | — |
现金转化率GTESRPRX
| Q4 25 | 5.26× | 3.86× | ||
| Q3 25 | 1.20× | 2.44× | ||
| Q2 25 | 1.82× | 12.06× | ||
| Q1 25 | 0.12× | 2.50× | ||
| Q4 24 | 5.22× | 3.57× | ||
| Q3 24 | 2.43× | 1.29× | ||
| Q2 24 | 1.33× | 6.45× | ||
| Q1 24 | -0.53× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GTES
| Power Transmission Segment | $536.5M | 63% |
| Fluid Power Segment | $319.7M | 37% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
